What is the recommended treatment for a patient with urethritis, potentially caused by a bacterial infection such as gonorrhea or chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urethritis

For acute urethritis, treat empirically with dual therapy: Ceftriaxone 250-500 mg IM single dose PLUS Doxycycline 100 mg orally twice daily for 7 days to cover both gonorrhea and chlamydia before culture results are available. 1

Initial Diagnostic Confirmation

Before initiating treatment, document objective evidence of urethritis using at least one of the following criteria:

  • Mucopurulent or purulent urethral discharge on examination 2, 1
  • Gram stain showing ≥5 white blood cells per oil immersion field 2, 1
  • Positive leukocyte esterase test on first-void urine 2, 1
  • Microscopic examination of first-void urine showing ≥10 white blood cells per high-power field 2, 1

All patients must be tested for both Neisseria gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification tests (NAATs), which are more sensitive than culture for chlamydia. 2, 1 Testing for both pathogens improves partner notification and treatment compliance. 3, 2

First-Line Treatment Regimen

Dual Therapy (Covers Both Gonorrhea and Chlamydia)

  • Ceftriaxone 250-500 mg IM single dose (for gonococcal coverage) 3, 1
  • PLUS Doxycycline 100 mg orally twice daily for 7 days (for chlamydial and nongonococcal urethritis coverage) 4, 1, 5

This dual approach is essential because co-infection is common, and delaying treatment increases risk of complications and ongoing transmission. 1 Most sexually transmitted urethritis in men under 35 years is caused by C. trachomatis or N. gonorrhoeae. 1, 6

Alternative Regimens for Chlamydial/Nongonococcal Component

If doxycycline cannot be used, the following alternatives are acceptable for the chlamydial component:

  • Azithromycin 1 g orally as a single dose 1, 7
  • Erythromycin base 500 mg orally four times daily for 7 days 4
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 4
  • Ofloxacin 300 mg orally twice daily for 7 days 4
  • Levofloxacin 500 mg orally once daily for 7 days 4

Critical Management Points

Sexual Activity Restrictions

  • Patients must abstain from sexual intercourse for 7 days after treatment initiation AND until symptoms resolve AND partners are adequately treated. 3, 1

Partner Management

  • All sexual partners within the preceding 60 days must be evaluated and treated with the same regimen as the index patient, regardless of symptoms or test results. 4, 3, 1
  • If the last sexual contact was more than 60 days before symptom onset, treat the most recent sexual partner. 3

Follow-Up

  • Patients should return for evaluation only if symptoms persist or recur after completing therapy. 4
  • Symptoms alone, without documentation of signs or laboratory evidence of urethral inflammation, are NOT sufficient basis for re-treatment. 4

Important Warnings and Contraindications

What NOT to Do for Gonococcal Urethritis

  • Do NOT use oral cephalosporins (like cefixime) for pharyngeal gonorrhea—they have unacceptably low cure rates (approximately 57%). 3
  • Do NOT use azithromycin monotherapy (even at 2 g dose) due to cost, gastrointestinal side effects, and concerns about rapid emergence of resistance. 3
  • Do NOT use fluoroquinolones (ciprofloxacin, ofloxacin) for gonorrhea due to widespread resistance, particularly in men who have sex with men and patients with recent foreign travel. 3
  • Do NOT use penicillins, tetracyclines, or macrolides as monotherapy for gonorrhea—N. gonorrhoeae in the United States is not adequately susceptible to these agents. 3

Pregnancy Considerations

  • Pregnant women should receive ceftriaxone 500 mg IM single dose for gonococcal infection. 3
  • Doxycycline and fluoroquinolones are absolutely contraindicated in pregnancy. 3

Recurrent or Persistent Urethritis

If symptoms persist after appropriate treatment:

  • Re-treat with the initial regimen if the patient did not comply with treatment or was re-exposed to an untreated sex partner. 4
  • If the patient was compliant and re-exposure can be excluded, perform culture of an intra-urethral swab and first-void urine for Trichomonas vaginalis. 4
  • Some cases of recurrent urethritis following doxycycline may be caused by tetracycline-resistant Ureaplasma urealyticum. 4

Recommended Regimen for Persistent/Recurrent Cases

  • Metronidazole 2 g orally in a single dose 4
  • PLUS Erythromycin base 500 mg orally four times daily for 7 days 4
  • OR Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 4

Special Populations

HIV-Infected Patients

  • HIV-infected patients should receive the same treatment regimen as HIV-negative patients—no modification is needed. 4, 3, 1
  • Gonococcal urethritis, chlamydial urethritis, and nongonococcal urethritis may facilitate HIV transmission. 4

Additional Considerations

  • All patients with sexually-transmitted urethritis should have serologic testing for syphilis and HIV performed at the time of diagnosis. 1, 7
  • Antimicrobial agents used in high doses for short periods may mask or delay symptoms of incubating syphilis. 7
  • Administer adequate fluids with doxycycline capsules/tablets to reduce risk of esophageal irritation and ulceration. 5
  • If gastric irritation occurs with doxycycline, give with food or milk—absorption is not markedly influenced by simultaneous food ingestion. 5

References

Guideline

Empiric Antibiotic Therapy for Suspected Urethritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Urethritis in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gonococcal Urethritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.